Amylyx Pharmaceuticals has named Dan Monahan as chief commercial officer, positioning an exec who led the U.S.

Medically reviewed by Brendan Camp, MD Hidradenitis suppurativa (HS) is a chronic (long-term) condition that causes painful ...

Secukinumab is under clinical development by Novartis and currently in Phase II for Unspecified Dermatological Disorders.

Secukinumab is under clinical development by Novartis and currently in Phase II for Coronavirus Disease 2019 (COVID-19) Pneumonia.

INR:6131. golden boot in football Novartis's Cosentyx for the treatment of radiographically negative axial spondyloarthritis is about to be approved! As o ...

INR:5902. morning teer result juwai AbbVie's Skyrizi head-to-head phase 3 study achieves all endpoints, superior to Cosentyx Hengrui's LAG-3 antibody ha ...

INR:8268. amazon gold coins Novartis's Cosentyx for the treatment of radiographically negative axial spondyloarthritis is about to be approved! Can dapoxetine h ...

INR:1868. clt frozenfluffies Novartis Cosentyx first-line treatment: rapid and powerful clearance of skin lesions and improved quality of life Puli Pharmaceuti ...

Chinese jade coin 48% of patients had improved liver fibrosis; Akero's innovative NASH therapy Phase 2a clinical results were positive Novartis' Cosen ...

INR:3515. rummy patta game "Pharmaceutical Speed ​​Reading Club" Amgen Enbrel patent wins the lawsuit and 9 drugs are suspended and recalled Novartis introdu ...

INR:9376. best online nfl betting site France's new coronavirus test method produces results within 10 minutes and can be used with smartphones The S ...

INR:5206. t 20 world cup live score Novartis' Cosentyx is approved by the EU to treat moderate to severe plaque psoriasis in patients aged 6-18 years FD ...